Navigation Links
Agent Orange Tied to Lethal Prostate Cancer
Date:5/13/2013

MONDAY, May 13 (HealthDay News) -- A link exists between exposure to Agent Orange and deadly forms of prostate cancer in U.S. veterans, according to a new study.

Agent Orange was a chemical spray that was heavily used during the Vietnam War era. It was often contaminated with dioxin, a potentially cancer-causing chemical. Previous research suggests that exposure to Agent Orange increases the risk of prostate cancer, but it wasn't known if it specifically increases the risk of more dangerous forms of the disease.

In this study, researchers looked at more than 2,700 U.S. veterans who underwent a prostate biopsy. Prostate cancer was diagnosed in 33 percent of the veterans, including 17 percent with high-grade disease, according to the study, which was published online May 13 in the journal Cancer.

Exposure to Agent Orange was linked with a 52 percent increase in overall prostate cancer risk, a 75 percent increased risk of high-grade prostate cancer and a more than doubled risk of the deadliest forms of the disease.

The findings suggest that determining veterans' exposure to Agent Orange can help identify those who may be at increased risk for prostate cancer, leading to earlier detection and treatment, said Dr. Mark Garzotto, of the Portland Veterans Administration Medical Center and Oregon Health & Science University, and colleagues.

"It also should raise awareness about potential harms of chemical contaminants in biologic agents used in warfare and the risks associated with waste handling and other chemical processes that generate dioxin or dioxin-related compounds," Garzotto said in a journal news release.

More information

The U.S. National Cancer Institute has more about prostate cancer.

-- Robert Preidt

SOURCE: Cancer, news release, May 13, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pig stomach mucins are effective as anti-viral agents for consumer products
2. Imaging agents predict breast cancer response to endocrine therapy
3. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
4. New substances 15,000 times more effective in destroying chemical warfare agents
5. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
6. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
7. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
8. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
9. Rilpivirine for HIV: Added benefit for single agent proven
10. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
11. Investigational agent targets gene signaling pathways to improve response for patients with CLL
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Agent Orange Tied to Lethal Prostate Cancer
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology: